Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.

Carini F, Barbano L, Saggese V, Monai D, Porcaro G.

Ann Stomatol (Roma). 2012 Apr;3(2 Suppl):32-6. Epub 2012 Nov 14.

PMID:
23285320
[PubMed]
Free PMC Article
2.

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.

Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.

Clin Ther. 2007 Aug;29(8):1548-58. Review.

PMID:
17919538
[PubMed - indexed for MEDLINE]
3.

Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.

Friedrich RE, Blake FA.

Anticancer Res. 2007 Jul-Aug;27(4A):1841-5.

PMID:
17649782
[PubMed - indexed for MEDLINE]
Free Article
4.

Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates.

Gebara SN, Moubayed H.

Am J Health Syst Pharm. 2009 Sep 1;66(17):1541-7. doi: 10.2146/ajhp080251. Review.

PMID:
19710437
[PubMed - indexed for MEDLINE]
5.

Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.

Grant BT, Amenedo C, Freeman K, Kraut RA.

J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019.

PMID:
18201600
[PubMed - indexed for MEDLINE]
6.

Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

Kunchur R, Need A, Hughes T, Goss A.

J Oral Maxillofac Surg. 2009 Jun;67(6):1167-73. doi: 10.1016/j.joms.2009.02.004.

PMID:
19446200
[PubMed - indexed for MEDLINE]
7.

Surgical protocol in patients at risk for bisphosphonate osteonecrosis of the jaws: clinical use of serum telopetide CTX in preventive monitoring of surgical risk.

Carini F, Saggese V, Porcaro G, Barbano L, Baldoni M.

Ann Stomatol (Roma). 2012 Jan;3(1):31-6. Epub 2012 May 3.

PMID:
22783453
[PubMed]
Free PMC Article
8.

Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.

Montazeri AH, Erskine JG, McQuaker IG.

Eur J Haematol. 2007 Jul;79(1):69-71.

PMID:
17598839
[PubMed - indexed for MEDLINE]
9.

Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.

Wang HL, Weber D, McCauley LK.

J Periodontol. 2007 Mar;78(3):584-94. Review.

PMID:
17335384
[PubMed - indexed for MEDLINE]
10.

Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.

Vescovi P, Nammour S.

Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Review. English, Italian.

PMID:
20360666
[PubMed - indexed for MEDLINE]
11.

Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S.

Osteoporos Int. 2007 Oct;18(10):1363-70. Epub 2007 Jun 28.

PMID:
17598065
[PubMed - indexed for MEDLINE]
12.

[Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].

Capsoni F.

Reumatismo. 2008 Jan-Mar;60(1):6-13. Review. Italian.

PMID:
18432320
[PubMed - indexed for MEDLINE]
13.

CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.

Lee CY, Suzuki JB.

Implant Dent. 2010 Feb;19(1):29-38. doi: 10.1097/ID.0b013e3181cec8bc.

PMID:
20147814
[PubMed - indexed for MEDLINE]
14.

Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.

King AE, Umland EM.

Pharmacotherapy. 2008 May;28(5):667-77. doi: 10.1592/phco.28.5.667. Review.

PMID:
18447663
[PubMed - indexed for MEDLINE]
15.

Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.

J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.

PMID:
19531404
[PubMed - indexed for MEDLINE]
16.

Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.

Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, Pautke C.

J Craniomaxillofac Surg. 2012 Jun;40(4):303-9. doi: 10.1016/j.jcms.2011.05.003. Epub 2011 Jun 14.

PMID:
21676622
[PubMed - indexed for MEDLINE]
17.

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.

Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE.

Intern Med J. 2009 May;39(5):304-16. doi: 10.1111/j.1445-5994.2008.01824.x. Epub 2008 Nov 3. Review.

PMID:
19220531
[PubMed - indexed for MEDLINE]
18.

Bone necrosis around dental implants: A patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX.

Flichy-Fernández AJ, González-Lemonnier S, Balaguer-Martínez J, Peñarrocha-Oltra D, Peñarrocha-Diago MA, Bagán-Sebastián JV.

J Clin Exp Dent. 2012 Feb 1;4(1):e82-5. doi: 10.4317/jced.50698. eCollection 2012 Feb.

PMID:
24558532
[PubMed]
Free PMC Article
19.

Practical considerations for treatment of patients taking bisphosphonate medications: an update.

Brock G, Barker K, Butterworth CJ, Rogers S.

Dent Update. 2011 Jun;38(5):313-4, 317-8, 321-4 passim. Review.

PMID:
21834312
[PubMed - indexed for MEDLINE]
20.

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

Migliorati CA, Schubert MM, Peterson DE, Seneda LM.

Cancer. 2005 Jul 1;104(1):83-93.

PMID:
15929121
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk